Identification of clinically relevant subgroups of COPD based on airway and circulating autoantibody profiles

  • Authors:
    • Zhenyu Liang
    • Fei Long
    • Fengyan Wang
    • Yuqiong Yang
    • Jing Xiao
    • Kuimiao Deng
    • Weili Gu
    • Luqian Zhou
    • Jiaxing Xie
    • Wenhua Jian
    • Xin Chen
    • Mei Jiang
    • Jinping Zheng
    • Tao Peng
    • Rongchang Chen
  • View Affiliations

  • Published online on: July 12, 2019     https://doi.org/10.3892/mmr.2019.10498
  • Pages: 2882-2892
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Autoimmunity may serve a role in the pathological features of a subgroup of patients with chronic obstructive pulmonary disease (COPD); however, in immunological subgroups of COPD patients, the interrelationships between airway and circulating autoantibody responses, and clinical parameters, remain unclear. The present study was undertaken to evaluate these interrelationships in various immunological subgroups of COPD patients. Sputum supernatant and serum obtained from 102 patients with stable COPD were assayed for the presence of immunoglobulin G antibodies against ten autoantigens via Luminex multiplex technology. Hierarchical clustering based on principal components was performed on autoantibody profiles to classify patients into clusters. Network‑based and module analyses were conducted to explore interrelationships among autoantibodies and clinical variables in each cluster. Topological characteristics were compared between clusters. Unsupervised clustering identified four clusters: No significant differences in the majority of clinical characteristics were observed among clusters. In cluster 1, retrospective exacerbation was only positively associated with COPD assessment test score. Lung functions (predicted % of forced expiratory volume in 1 sec and maximal mid‑expiratory flow) were negatively associated with exacerbation risk only in cluster 2. Sputum autoantibodies (against U1 small nuclear ribonucleoprotein, proteinase‑3 and Ro/Sjögren syndrome type A antigen) were negatively associated with exacerbation risks in cluster 2, but positively associated in cluster 3. The four networks also exhibited distinct topological properties. In COPD, autoantibody responses were heterogeneous and differentially associated with exacerbation risk in certain subgroups; their dual character should be considered in future research.
View Figures
View References

Related Articles

Journal Cover

September 2019
Volume 20 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liang, Z., Long, F., Wang, F., Yang, Y., Xiao, J., Deng, K. ... Chen, R. (2019). Identification of clinically relevant subgroups of COPD based on airway and circulating autoantibody profiles. Molecular Medicine Reports, 20, 2882-2892. https://doi.org/10.3892/mmr.2019.10498
MLA
Liang, Z., Long, F., Wang, F., Yang, Y., Xiao, J., Deng, K., Gu, W., Zhou, L., Xie, J., Jian, W., Chen, X., Jiang, M., Zheng, J., Peng, T., Chen, R."Identification of clinically relevant subgroups of COPD based on airway and circulating autoantibody profiles". Molecular Medicine Reports 20.3 (2019): 2882-2892.
Chicago
Liang, Z., Long, F., Wang, F., Yang, Y., Xiao, J., Deng, K., Gu, W., Zhou, L., Xie, J., Jian, W., Chen, X., Jiang, M., Zheng, J., Peng, T., Chen, R."Identification of clinically relevant subgroups of COPD based on airway and circulating autoantibody profiles". Molecular Medicine Reports 20, no. 3 (2019): 2882-2892. https://doi.org/10.3892/mmr.2019.10498